We developed a sandwich enzyme immunoassay for determining cystatin C in serum by using commercially available antibodies. We optimized each assay step (e.g., concentrations of coating rabbit anti-human cystatin C antibodies and horseradish peroxidase-conjugated antibodies) and studied the binding kinetics of antigen and antibodies. The within-assay cv was <5%, the betweenassay CV was 8.8%, the detection limitwas 0.9 /.Lg/L,and the assay can be performed within 2 h. Cystatin C concentrations in sera from men were significantly higher than in women (mean and SD: 2.14 ± 0.31 vs 1.78 ± 0.26 mg/L). We studied the cystatin C concentrations in sera of 31 outpatients with suspected kidney damages to characterize the behavior of this Iow-M, protein as a possible indicator for estimating the glomerular filtration rate. The correlation with the values obtained by a standard isotopic method involving mtTITcdiethylenetriaminopentaacetic acid was r5 = -0.89. The diagnostic sensitivityof cystatin C was 88.2% of that of the standard isotope clearance method and better than those of the conventional serum indicators of reduced kidney function, 2-microglobulin (64.7%) and creatinine (52.9%).
IndexingTerms:
proteins . renal function . glomerular filtration rate -sex-related effects . diagnostic sensitivity Human cystatin C, previously named gamma-trace or post-gamma-globulin, is a low-molecular-mass protein of -13 kfla that inhibits cysteine proteinases and has been found in several human body fluids (1). In 1961, Clausen (2) reported its occurrence in cerebrospinal fluid but he could not detect it in serum. That same year, it was found in urine from patients with renal failure (3). Its primary structure, physicochemical and immunological properties, and tissue distribution have been described, but its biological function is as yet unknown (1, 4). The cystatin C concentration in human serum, urine, cerebrospinal fluid, saliva, semen, colostrum, ascitic fluid, and pleural fluid is very low and makes high demands on the analytical sensitivity and specificity of determination methods. C. Subsequently, simpler and more-sensitive radio-, fluorescence-, and various enzyme immunoassays were developed to improve the analytical reliability of the methods (7-12; Table 1 ). However, the diagnostic value of cystatin C was not clearly confirmed by those investigators-perhaps a result of the general difficulties of standardizing immunological methods.
The antigens and antibodies used in the previous tests were mostly prepared in house, and the differences in heterogeneity and purity attributable to the various isolation procedures used influenced the assay qualities. We describe here the development of a sensitive and rapid heterogeneous enzyme immunoassay based on, for the first time, the use of commercially available antihuman cystatin C antibodies.
We also present our first preliminary data on the diagnostic validity of this assay in comparison with a standard isotopic method based on 99'Te-diethylenetnaminopentaacetic acid (DTPA) clearance and with the conventional renal markers /32-microglobulin and creatinine. 
Materials and Methods

Materials
Subjects and Samples
Serum samples from healthy blood donors, 33 men (ages 24 to63y) and 33 women (ages 19 to 61 years), were investigated for determination of reference intervals. We also studied samples from a group of 31 outpatients with suspected kidney diseases: 9 men (ages 20 to 66 years) and 22 women (ages 18 to 73 years). Blood samples were collected in tubes at room temperature, centrifuged without delay, and analyzed on the same day or at the latest within a week after storage at -20#{176}C.
Before assay, the serum samples were diluted (usually 150-fold) with dilution buffer.
Methods
In the patients, the DTPA isotope clearance was mea- Figure  1 .
Resufts
Development of the Assay
Antibody and conjugate concentration. (Figure 3, right) . We selected an incubation time of 60 miii for the conjugate binding.
Assay Validation
Detection limit, precision, and recovery. The detection limit was defined as the mean +3 SD of the blank value expressed as cystatin C concentration and calculated from the measured absorbances of 20 determinations of the buffer solution without antigen in the assay. The detection limit for cystatin C was thus 0.9 gfL.
The within-assay variation (n = 11) was 5.0%, 4.6%, and 2.8% for human pooled serum diluted to yield cystatin C concentrations of 2.6, 11.3, and 24.4 i.g/L, respectively. The between-assay variation was determined by duplicate measurement on 10 days of a human serum (2.67 mgfL) diluted to contain cystatin C at 17.8 gIL. The CV obtained was 8.8%.
Analytical recovery experiments
were carried out by assaying different mixtures of two diluted human pooled sera having different cystatin C concentrations (54 and 2.6 tg/L). The results are shown in Figure 4 .
Cystatin C concentrations in serum of heoithy subjects. The serum concentration of cystatin C was measured in 33 men (mean age ± SD, 40 ± 12 years) and 33 women (37 ± 12 years). The values were not age-dependent (r8 = 0.07) but were influenced by sex ( Figure 5) . We found normal distributions of cystatin C concentrations, but the values in women were significantly lower (mean ± SD, 1.78 ± 0.26 mgIL) than in men (2.14 ± 0.31 mgfL; P <0.00 1). Therefore, we calculated the sex-dependent upper reference limits as mean + 1.96 SD, using the central 95% reference interval as the basis (17). The cutoff values were thus 2.75 mgfL for men and 2.29 mgfL for women.
Cystatin C and other serum markers in patients with kidney diseases. In our outpatient group, the concentrations of cystatin C were 3.20 ± 1.98 mg'L (mean ± SD), (-microglobulin Table 2 . On this basis, diagnostic sensitivities and specificities for cystatin C, /32-microglobulin, and creatinine were compared. The diagnostic sensitivity of cystatin C was higher than the corresponding data of J3-microglobulin and creatinune ( Table 2) .
The relationship of serum cystatin C to the DTPA clearance is shown in Figure 6 
100
DTPA dearance was used as the Indicator of reduced glomeruiarfiltration ratesand formed the basis for the calculations of sensitivity and specificity. Seventeen patients had values belowthe cutoff limit of 1.36 mI/s (16). The cutofflimits for cystatin C were 2.29 mg/I forwomen, 2.75 mg/I for men; for p.-mlcroglobuIin, 2.75 maJL forcreatlnine, 97 jmoi/I forwomen, 106 moUL formen. 
